These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28900035)

  • 21. MST1 Negatively Regulates TNFα-Induced NF-κB Signaling through Modulating LUBAC Activity.
    Lee IY; Lim JM; Cho H; Kim E; Kim Y; Oh HK; Yang WS; Roh KH; Park HW; Mo JS; Yoon JH; Song HK; Choi EJ
    Mol Cell; 2019 Mar; 73(6):1138-1149.e6. PubMed ID: 30901564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha).
    Yamaguchi T; Kimura J; Miki Y; Yoshida K
    J Biol Chem; 2007 Nov; 282(47):33943-8. PubMed ID: 17897950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenoviral vector expressing CYLD augments antitumor activity of TRAIL by suppression of NF-kappaB survival signaling in hepatocellular carcinoma.
    Chu L; Gu J; He Z; Xiao T; Liu X
    Cancer Biol Ther; 2006 Jun; 5(6):615-22. PubMed ID: 16627981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase.
    Takeuchi J; Hirota K; Itoh T; Shinkura R; Kitada K; Yodoi J; Namba T; Fukuda K
    Antioxid Redox Signal; 2000; 2(1):83-92. PubMed ID: 11232604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
    Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
    Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
    Kovalenko A; Chable-Bessia C; Cantarella G; Israël A; Wallach D; Courtois G
    Nature; 2003 Aug; 424(6950):801-5. PubMed ID: 12917691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.
    Funakoshi-Tago M; Kamada N; Shimizu T; Hashiguchi Y; Tago K; Sonoda Y; Kasahara T
    Cytokine; 2009 Feb; 45(2):72-9. PubMed ID: 19091594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
    Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
    Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verproside inhibits TNF-α-induced MUC5AC expression through suppression of the TNF-α/NF-κB pathway in human airway epithelial cells.
    Lee SU; Sung MH; Ryu HW; Lee J; Kim HS; In HJ; Ahn KS; Lee HJ; Lee HK; Shin DH; Lee Y; Hong ST; Oh SR
    Cytokine; 2016 Jan; 77():168-75. PubMed ID: 26318254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.
    Kim YS; Nedospasov SA; Liu ZG
    Mol Cell Biol; 2005 Mar; 25(6):2130-7. PubMed ID: 15743811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products.
    Ahn KS; Sethi G; Aggarwal BB
    Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Casein kinase 1alpha interacts with RIP1 and regulates NF-kappaB activation.
    Wang Y; Sun X; Wu J; Xu BE; Gu C; Wang H; Wang X; Tan F; Peng X; Qiang B; Yuan J; Luo Y
    Biochemistry; 2008 Jan; 47(1):441-8. PubMed ID: 18067272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
    Zhang LM; Zhou JJ; Luo CL
    Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Y14 positively regulates TNF-α-induced NF-κB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein.
    Togi S; Shiga K; Muromoto R; Kato M; Souma Y; Sekine Y; Kon S; Oritani K; Matsuda T
    J Immunol; 2013 Aug; 191(3):1436-44. PubMed ID: 23817415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
    Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
    J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor.
    Regamey A; Hohl D; Liu JW; Roger T; Kogerman P; Toftgard R; Huber M
    J Exp Med; 2003 Dec; 198(12):1959-64. PubMed ID: 14676304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
    J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.